Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 28% ± 9% | |
lung | 10 studies | 28% ± 10% | |
intestine | 8 studies | 23% ± 11% | |
kidney | 7 studies | 23% ± 4% | |
liver | 5 studies | 31% ± 21% | |
lymph node | 4 studies | 22% ± 4% | |
pancreas | 3 studies | 27% ± 6% | |
bone marrow | 3 studies | 22% ± 4% | |
breast | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 1935.13 | 359 / 359 | 10% | 0.17 | 28 / 286 |
intestine | 100% | 2536.21 | 966 / 966 | 9% | 0.15 | 45 / 527 |
bladder | 100% | 2331.38 | 21 / 21 | 5% | 0.09 | 24 / 504 |
esophagus | 100% | 2333.50 | 1445 / 1445 | 2% | 0.02 | 3 / 183 |
lung | 100% | 2271.05 | 578 / 578 | 0% | 0.00 | 3 / 1155 |
prostate | 100% | 2392.71 | 245 / 245 | 0% | 0.00 | 1 / 502 |
breast | 100% | 2519.91 | 459 / 459 | 0% | 0.00 | 2 / 1118 |
kidney | 100% | 2539.85 | 89 / 89 | 0% | 0.00 | 1 / 901 |
adipose | 100% | 2405.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 100% | 3148.65 | 258 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 100% | 2550.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
liver | 100% | 1411.38 | 226 / 226 | 0% | 0 | 0 / 406 |
ovary | 100% | 2271.41 | 180 / 180 | 0% | 0 | 0 / 430 |
skin | 100% | 2662.45 | 1809 / 1809 | 0% | 0 | 0 / 472 |
spleen | 100% | 2790.85 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 100% | 2066.26 | 653 / 653 | 0% | 0 | 0 / 605 |
uterus | 100% | 2531.20 | 170 / 170 | 0% | 0 | 0 / 459 |
brain | 100% | 2301.33 | 2640 / 2642 | 0% | 0 | 0 / 705 |
peripheral blood | 100% | 4310.82 | 928 / 929 | 0% | 0 | 0 / 0 |
muscle | 100% | 1953.78 | 802 / 803 | 0% | 0 | 0 / 0 |
pancreas | 99% | 1047.32 | 326 / 328 | 0% | 0 | 0 / 178 |
heart | 98% | 1620.63 | 843 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0034243 | Biological process | regulation of transcription elongation by RNA polymerase II |
GO_0032785 | Biological process | negative regulation of DNA-templated transcription, elongation |
GO_0032786 | Biological process | positive regulation of DNA-templated transcription, elongation |
GO_0034244 | Biological process | negative regulation of transcription elongation by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0140673 | Biological process | transcription elongation-coupled chromatin remodeling |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0032044 | Cellular component | DSIF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0000993 | Molecular function | RNA polymerase II complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | SUPT4H1 |
Protein name | Transcription elongation factor SPT4 SPT4 homolog, DSIF elongation factor subunit SPT4 homolog, DSIF elongation factor subunit (Suppressor of Ty 4 homolog 1 (S. cerevisiae), isoform CRA_b) Transcription elongation factor SPT4 (hSPT4) (DRB sensitivity-inducing factor 14 kDa subunit) (DSIF p14) (DRB sensitivity-inducing factor small subunit) (DSIF small subunit) |
Synonyms | SUPT4H SPT4H hCG_2002775 |
Description | FUNCTION: Component of the DRB sensitivity-inducing factor complex (DSIF complex), which regulates mRNA processing and transcription elongation by RNA polymerase II. DSIF positively regulates mRNA capping by stimulating the mRNA guanylyltransferase activity of RNGTT/CAP1A. DSIF also acts cooperatively with the negative elongation factor complex (NELF complex) to enhance transcriptional pausing at sites proximal to the promoter. Transcriptional pausing may facilitate the assembly of an elongation competent RNA polymerase II complex. DSIF and NELF promote pausing by inhibition of the transcription elongation factor TFIIS/S-II. TFIIS/S-II binds to RNA polymerase II at transcription pause sites and stimulates the weak intrinsic nuclease activity of the enzyme. Cleavage of blocked transcripts by RNA polymerase II promotes the resumption of transcription from the new 3' terminus and may allow repeated attempts at transcription through natural pause sites. DSIF can also positively regulate transcriptional elongation and is required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat. DSIF acts to suppress transcriptional pausing in transcripts derived from the HIV-1 LTR and blocks premature release of HIV-1 transcripts at terminator sequences. . FUNCTION: Component of the DRB sensitivity-inducing factor complex (DSIF complex), which regulates transcription elongation by RNA polymerase II. . |
Accessions | ENST00000579289.1 ENST00000225504.8 J3QSB9 ENST00000580947.1 ENST00000577396.5 J3KSQ6 P63272 ENST00000581540.5 D3DTZ5 |